世界の眼科薬市場インサイト及び予測(~2026年)

【英語タイトル】Global Ophthalmol Drugs Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV08384)・商品コード:QYR20NV08384
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは眼科薬の世界市場について調査・分析した資料です。種類別(網膜障害薬、アレルギー薬、炎症薬、感染薬、緑内障薬、ドライアイ薬)の市場規模、用途別(緑内障、ドライアイ症候群、網膜疾患、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別眼科薬の競争状況、市場シェア
・世界の眼科薬市場:種類別市場規模 2015年-2020年(網膜障害薬、アレルギー薬、炎症薬、感染薬、緑内障薬、ドライアイ薬)
・世界の眼科薬市場:種類別市場規模予測 2021年-2026年(網膜障害薬、アレルギー薬、炎症薬、感染薬、緑内障薬、ドライアイ薬)
・世界の眼科薬市場:用途別市場規模 2015年-2020年(緑内障、ドライアイ症候群、網膜疾患、その他)
・世界の眼科薬市場:用途別市場規模予測 2021年-2026年(緑内障、ドライアイ症候群、網膜疾患、その他)
・北米の眼科薬市場分析:米国、カナダ
・ヨーロッパの眼科薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの眼科薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の眼科薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの眼科薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Novartis、Allergan、Roche、Valeant、Regeneron、Santen、Bayer、Pfizer、Senju、Akorn
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Ophthalmol Drugs Market
The global Ophthalmol Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Ophthalmol Drugs Scope and Market Size
Ophthalmol Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmol Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Ophthalmol Drugs market is segmented into
Retinal Disorders Drugs
Allergic, Inflammatory and Infective Drugs
Glaucoma Drugs
Dry Eye Drugs

Segment by Application, the Ophthalmol Drugs market is segmented into
Glaucoma
Dry Eye Syndrome
Retinal Diseases
Other Ophthalmic Indications

Regional and Country-level Analysis
The Ophthalmol Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ophthalmol Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ophthalmol Drugs Market Share Analysis
Ophthalmol Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmol Drugs business, the date to enter into the Ophthalmol Drugs market, Ophthalmol Drugs product introduction, recent developments, etc.

The major vendors covered:
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn

【レポートの目次】

1 Study Coverage
1.1 Ophthalmol Drugs Product Introduction
1.2 Market Segments
1.3 Key Ophthalmol Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ophthalmol Drugs Market Size Growth Rate by Type
1.4.2 Retinal Disorders Drugs
1.4.3 Allergic, Inflammatory and Infective Drugs
1.4.4 Glaucoma Drugs
1.4.5 Dry Eye Drugs
1.5 Market by Application
1.5.1 Global Ophthalmol Drugs Market Size Growth Rate by Application
1.5.2 Glaucoma
1.5.3 Dry Eye Syndrome
1.5.4 Retinal Diseases
1.5.5 Other Ophthalmic Indications
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Ophthalmol Drugs Market Size, Estimates and Forecasts
2.1.1 Global Ophthalmol Drugs Revenue 2015-2026
2.1.2 Global Ophthalmol Drugs Sales 2015-2026
2.2 Global Ophthalmol Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ophthalmol Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ophthalmol Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Ophthalmol Drugs Competitor Landscape by Players
3.1 Ophthalmol Drugs Sales by Manufacturers
3.1.1 Ophthalmol Drugs Sales by Manufacturers (2015-2020)
3.1.2 Ophthalmol Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Ophthalmol Drugs Revenue by Manufacturers
3.2.1 Ophthalmol Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Ophthalmol Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ophthalmol Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ophthalmol Drugs Revenue in 2019
3.2.5 Global Ophthalmol Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ophthalmol Drugs Price by Manufacturers
3.4 Ophthalmol Drugs Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmol Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmol Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmol Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ophthalmol Drugs Market Size by Type (2015-2020)
4.1.1 Global Ophthalmol Drugs Sales by Type (2015-2020)
4.1.2 Global Ophthalmol Drugs Revenue by Type (2015-2020)
4.1.3 Ophthalmol Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ophthalmol Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Ophthalmol Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Ophthalmol Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Ophthalmol Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ophthalmol Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Ophthalmol Drugs Market Size by Application (2015-2020)
5.1.1 Global Ophthalmol Drugs Sales by Application (2015-2020)
5.1.2 Global Ophthalmol Drugs Revenue by Application (2015-2020)
5.1.3 Ophthalmol Drugs Price by Application (2015-2020)
5.2 Ophthalmol Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Ophthalmol Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Ophthalmol Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Ophthalmol Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Ophthalmol Drugs by Country
6.1.1 North America Ophthalmol Drugs Sales by Country
6.1.2 North America Ophthalmol Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ophthalmol Drugs Market Facts & Figures by Type
6.3 North America Ophthalmol Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Ophthalmol Drugs by Country
7.1.1 Europe Ophthalmol Drugs Sales by Country
7.1.2 Europe Ophthalmol Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ophthalmol Drugs Market Facts & Figures by Type
7.3 Europe Ophthalmol Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Ophthalmol Drugs by Region
8.1.1 Asia Pacific Ophthalmol Drugs Sales by Region
8.1.2 Asia Pacific Ophthalmol Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ophthalmol Drugs Market Facts & Figures by Type
8.3 Asia Pacific Ophthalmol Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Ophthalmol Drugs by Country
9.1.1 Latin America Ophthalmol Drugs Sales by Country
9.1.2 Latin America Ophthalmol Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ophthalmol Drugs Market Facts & Figures by Type
9.3 Central & South America Ophthalmol Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Ophthalmol Drugs by Country
10.1.1 Middle East and Africa Ophthalmol Drugs Sales by Country
10.1.2 Middle East and Africa Ophthalmol Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ophthalmol Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Ophthalmol Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Ophthalmol Drugs Products Offered
11.1.5 Novartis Related Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description and Business Overview
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Ophthalmol Drugs Products Offered
11.2.5 Allergan Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Ophthalmol Drugs Products Offered
11.3.5 Roche Related Developments
11.4 Valeant
11.4.1 Valeant Corporation Information
11.4.2 Valeant Description and Business Overview
11.4.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Valeant Ophthalmol Drugs Products Offered
11.4.5 Valeant Related Developments
11.5 Regeneron
11.5.1 Regeneron Corporation Information
11.5.2 Regeneron Description and Business Overview
11.5.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Regeneron Ophthalmol Drugs Products Offered
11.5.5 Regeneron Related Developments
11.6 Santen
11.6.1 Santen Corporation Information
11.6.2 Santen Description and Business Overview
11.6.3 Santen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Santen Ophthalmol Drugs Products Offered
11.6.5 Santen Related Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Description and Business Overview
11.7.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bayer Ophthalmol Drugs Products Offered
11.7.5 Bayer Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Ophthalmol Drugs Products Offered
11.8.5 Pfizer Related Developments
11.9 Senju
11.9.1 Senju Corporation Information
11.9.2 Senju Description and Business Overview
11.9.3 Senju Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Senju Ophthalmol Drugs Products Offered
11.9.5 Senju Related Developments
11.10 Akorn
11.10.1 Akorn Corporation Information
11.10.2 Akorn Description and Business Overview
11.10.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Akorn Ophthalmol Drugs Products Offered
11.10.5 Akorn Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Ophthalmol Drugs Products Offered
11.1.5 Novartis Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ophthalmol Drugs Market Estimates and Projections by Region
12.1.1 Global Ophthalmol Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Ophthalmol Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Ophthalmol Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Ophthalmol Drugs Sales Forecast (2021-2026)
12.2.2 North America: Ophthalmol Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Ophthalmol Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Ophthalmol Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Ophthalmol Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Ophthalmol Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Ophthalmol Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ophthalmol Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ophthalmol Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ophthalmol Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ophthalmol Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Ophthalmol Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Ophthalmol Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Ophthalmol Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Ophthalmol Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ophthalmol Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ophthalmol Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ophthalmol Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ophthalmol Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ophthalmol Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ophthalmol Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Ophthalmol Drugs Market Segments
Table 2. Ranking of Global Top Ophthalmol Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ophthalmol Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Retinal Disorders Drugs
Table 5. Major Manufacturers of Allergic, Inflammatory and Infective Drugs
Table 6. Major Manufacturers of Glaucoma Drugs
Table 7. Major Manufacturers of Dry Eye Drugs
Table 8. Global Ophthalmol Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Ophthalmol Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Ophthalmol Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Ophthalmol Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Ophthalmol Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Ophthalmol Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Ophthalmol Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Ophthalmol Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Ophthalmol Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmol Drugs as of 2019)
Table 17. Ophthalmol Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Ophthalmol Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Ophthalmol Drugs Price (2015-2020) (USD/MT)
Table 20. Ophthalmol Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Ophthalmol Drugs Product Type
Table 22. Date of International Manufacturers Enter into Ophthalmol Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Ophthalmol Drugs Sales by Type (2015-2020) (K MT)
Table 25. Global Ophthalmol Drugs Sales Share by Type (2015-2020)
Table 26. Global Ophthalmol Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Ophthalmol Drugs Revenue Share by Type (2015-2020)
Table 28. Ophthalmol Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Ophthalmol Drugs Sales by Application (2015-2020) (K MT)
Table 30. Global Ophthalmol Drugs Sales Share by Application (2015-2020)
Table 31. North America Ophthalmol Drugs Sales by Country (2015-2020) (K MT)
Table 32. North America Ophthalmol Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Ophthalmol Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Ophthalmol Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Ophthalmol Drugs Sales by Type (2015-2020) (K MT)
Table 36. North America Ophthalmol Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Ophthalmol Drugs Sales by Application (2015-2020) (K MT)
Table 38. North America Ophthalmol Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Ophthalmol Drugs Sales by Country (2015-2020) (K MT)
Table 40. Europe Ophthalmol Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Ophthalmol Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Ophthalmol Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Ophthalmol Drugs Sales by Type (2015-2020) (K MT)
Table 44. Europe Ophthalmol Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Ophthalmol Drugs Sales by Application (2015-2020) (K MT)
Table 46. Europe Ophthalmol Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Ophthalmol Drugs Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Ophthalmol Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Ophthalmol Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Ophthalmol Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Ophthalmol Drugs Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Ophthalmol Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Ophthalmol Drugs Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Ophthalmol Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Ophthalmol Drugs Sales by Country (2015-2020) (K MT)
Table 56. Latin America Ophthalmol Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Ophthalmol Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Ophthalmol Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Ophthalmol Drugs Sales by Type (2015-2020) (K MT)
Table 60. Latin America Ophthalmol Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Ophthalmol Drugs Sales by Application (2015-2020) (K MT)
Table 62. Latin America Ophthalmol Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Ophthalmol Drugs Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Ophthalmol Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Ophthalmol Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Ophthalmol Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Ophthalmol Drugs Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Ophthalmol Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Ophthalmol Drugs Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Ophthalmol Drugs Sales Market Share by Application (2015-2020)
Table 71. Novartis Corporation Information
Table 72. Novartis Description and Major Businesses
Table 73. Novartis Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Novartis Product
Table 75. Novartis Recent Development
Table 76. Allergan Corporation Information
Table 77. Allergan Description and Major Businesses
Table 78. Allergan Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Allergan Product
Table 80. Allergan Recent Development
Table 81. Roche Corporation Information
Table 82. Roche Description and Major Businesses
Table 83. Roche Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Roche Product
Table 85. Roche Recent Development
Table 86. Valeant Corporation Information
Table 87. Valeant Description and Major Businesses
Table 88. Valeant Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Valeant Product
Table 90. Valeant Recent Development
Table 91. Regeneron Corporation Information
Table 92. Regeneron Description and Major Businesses
Table 93. Regeneron Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Regeneron Product
Table 95. Regeneron Recent Development
Table 96. Santen Corporation Information
Table 97. Santen Description and Major Businesses
Table 98. Santen Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Santen Product
Table 100. Santen Recent Development
Table 101. Bayer Corporation Information
Table 102. Bayer Description and Major Businesses
Table 103. Bayer Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Bayer Product
Table 105. Bayer Recent Development
Table 106. Pfizer Corporation Information
Table 107. Pfizer Description and Major Businesses
Table 108. Pfizer Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Pfizer Product
Table 110. Pfizer Recent Development
Table 111. Senju Corporation Information
Table 112. Senju Description and Major Businesses
Table 113. Senju Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Senju Product
Table 115. Senju Recent Development
Table 116. Akorn Corporation Information
Table 117. Akorn Description and Major Businesses
Table 118. Akorn Ophthalmol Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Akorn Product
Table 120. Akorn Recent Development
Table 121. Global Ophthalmol Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 122. Global Ophthalmol Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global Ophthalmol Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global Ophthalmol Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: Ophthalmol Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 126. North America: Ophthalmol Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: Ophthalmol Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 128. Europe: Ophthalmol Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: Ophthalmol Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 130. Asia Pacific: Ophthalmol Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: Ophthalmol Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 132. Latin America: Ophthalmol Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: Ophthalmol Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 134. Middle East and Africa: Ophthalmol Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Ophthalmol Drugs Players
Table 139. Ophthalmol Drugs Customers List
Table 140. Ophthalmol Drugs Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmol Drugs Product Picture
Figure 2. Global Ophthalmol Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Retinal Disorders Drugs Product Picture
Figure 4. Allergic, Inflammatory and Infective Drugs Product Picture
Figure 5. Glaucoma Drugs Product Picture
Figure 6. Dry Eye Drugs Product Picture
Figure 7. Global Ophthalmol Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Glaucoma
Figure 9. Dry Eye Syndrome
Figure 10. Retinal Diseases
Figure 11. Other Ophthalmic Indications
Figure 12. Ophthalmol Drugs Report Years Considered
Figure 13. Global Ophthalmol Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Ophthalmol Drugs Sales 2015-2026 (K MT)
Figure 15. Global Ophthalmol Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Ophthalmol Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Ophthalmol Drugs Sales Market Share by Region in 2019
Figure 18. Global Ophthalmol Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Ophthalmol Drugs Revenue Market Share by Region in 2019
Figure 20. Global Ophthalmol Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Ophthalmol Drugs Revenue in 2019
Figure 22. Ophthalmol Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Ophthalmol Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Ophthalmol Drugs Sales Market Share by Type in 2019
Figure 25. Global Ophthalmol Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Ophthalmol Drugs Revenue Market Share by Type in 2019
Figure 27. Global Ophthalmol Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Ophthalmol Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Ophthalmol Drugs Sales Market Share by Application in 2019
Figure 30. Global Ophthalmol Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Ophthalmol Drugs Revenue Market Share by Application in 2019
Figure 32. North America Ophthalmol Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Ophthalmol Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Ophthalmol Drugs Sales Market Share by Country in 2019
Figure 35. North America Ophthalmol Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Ophthalmol Drugs Market Share by Type in 2019
Figure 41. North America Ophthalmol Drugs Market Share by Application in 2019
Figure 42. Europe Ophthalmol Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Ophthalmol Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Ophthalmol Drugs Sales Market Share by Country in 2019
Figure 45. Europe Ophthalmol Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Ophthalmol Drugs Market Share by Type in 2019
Figure 57. Europe Ophthalmol Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Ophthalmol Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Ophthalmol Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Ophthalmol Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Ophthalmol Drugs Revenue Market Share by Region in 2019
Figure 62. China Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Ophthalmol Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Ophthalmol Drugs Market Share by Application in 2019
Figure 86. Latin America Ophthalmol Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Ophthalmol Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Ophthalmol Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Ophthalmol Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Ophthalmol Drugs Market Share by Type in 2019
Figure 97. Latin America Ophthalmol Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Ophthalmol Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Ophthalmol Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Ophthalmol Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Ophthalmol Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Ophthalmol Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Ophthalmol Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Ophthalmol Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Ophthalmol Drugs Market Share by Application in 2019
Figure 110. North America Ophthalmol Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Ophthalmol Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Ophthalmol Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Ophthalmol Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Ophthalmol Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Ophthalmol Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Ophthalmol Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Ophthalmol Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Ophthalmol Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Ophthalmol Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed


【掲載企業】

Novartis、Allergan、Roche、Valeant、Regeneron、Santen、Bayer、Pfizer、Senju、Akorn

★調査レポート[世界の眼科薬市場インサイト及び予測(~2026年)] (コード:QYR20NV08384)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の眼科薬市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆